Abstract
The aim of this study was to evaluate expression of COX-1 in renal cell carcinoma (RCC) and its prognostic value. mRNA of COX-1 was detected in 42 paired RCC and adjacent normal tissues with quantitative realtime polymerase chain reaction (qRT-PCR). Expression of COX-1 was also evaluated in 196 RCC sections and 91 adjacent normal tissues with immunohistochemistry. Statistical analysis was performed to assess COX-1 expression in RCC and its prognostic significance. The results of qRT-PCR showed mRNA levels of COX-1 in RCC tissues to be significantly higher than that in adjacent normal tissues (p < 0.001). Immunohistochemical assays also revealed COX-1 to be overexpressed in RCC tissues (p < 0.001). Statistical analysis demonstrated high expression of COX-1 was correlated with tumour size (p = 0.002), pathological stage (p = 0.003), TNM stage (p = 0.003, 0.007, 0.027, respectively), and tumour recurrence (p < 0.001). Survival analysis indicated patients with high expression of COX-1 had shorter survival time (p < 0.001), and COX-1 was an independentpredictor. This is the first study to reveal overexpression of COX-1 in RRC and point to use as a prognostic marker in affected patients.
Author supplied keywords
Cite
CITATION STYLE
Yu, Z. H., Zhang, Q., Wang, Y. D., Chen, J., Jiang, Z. M., Shi, M., … Lai, Y. Q. (2013). Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma. Asian Pacific Journal of Cancer Prevention, 14(6), 3729–3734. https://doi.org/10.7314/APJCP.2013.14.6.3729
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.